Established in 2000, NovaBay Pharmaceuticals initially focused on creating eye care solutions. Today, the company is shifting its focus to the Sky protocol and stablecoins, showcasing a significant shift in strategy. With over two decades of experience in the industry, NovaBay Pharmaceuticals is now investing heavily in these new ventures, indicating a growing interest in emerging technologies.